Recent Finacing
Recent Raise
ONK Therapeutics engineers off-the-shelf NK cell therapies combining CARs with membrane TRAILv and gene edits (CISH, CD38, checkpoint deletions), advancing IND‑enabling studies and GMP process development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
